Global CBD (Cannabidiol) Market Research Report 2020

Cannabidiol, or CBD, is the non-psychoactive cannabinoid famed for significantly reducing symptoms in patients suffering from seizure and spasm disorders such as epilepsy and multiple sclerosis. CBD is the cannabinoid most often recommended for children, elderly and other patients who must remain clear-headed in their activities because it is non-psychoactive, meaning it will not produce euphoria or the feeling of being “high.”CBD reacts with cannabinoid receptors throughout the human body and works to relieve inflammation and pain while producing a calming effect in patients. For this reason, it is often used to treat anxiety and sleep disorders. It has also been shown to work with THC to reduce the size of tumors.
Cannabidiol, or CBD, is the non-psychoactive cannabinoid famed for significantly reducing symptoms in patients suffering from seizure and spasm disorders such as epilepsy and multiple sclerosis. CBD is the cannabinoid most often recommended for children, elderly and other patients who must remain clear-headed in their activities because it is non-psychoactive, meaning it will not produce euphoria or the feeling of being “high.”CBD reacts with cannabinoid receptors throughout the human body and works to relieve inflammation and pain while producing a calming effect in patients. For this reason, it is often used to treat anxiety and sleep disorders. It has also been shown to work with THC to reduce the size of tumors.

The global CBD (Cannabidiol) market is valued at US$ xx million in 2019 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
This report focuses on CBD (Cannabidiol) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall CBD (Cannabidiol) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the CBD (Cannabidiol) market is segmented into
Oil
Capsule
Extract
Other

Segment by Application
Food
Cosmetics
Pharmaceutical
Other

Global CBD (Cannabidiol) Market: Regional Analysis
The CBD (Cannabidiol) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the CBD (Cannabidiol) market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global CBD (Cannabidiol) Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global CBD (Cannabidiol) market include:
Trulieve
Curaleaf
MedMen
Green Thumb Industries
Cresco Labs
Harvest House of Cannabis
Columbia Care
Acreage Holdings
Halo
Planet 13